Emergent BioSolutions, Inc. (EBS)
6.23
+0.36
(+6.13%)
USD |
NYSE |
Sep 11, 16:00
6.08
-0.15
(-2.41%)
Pre-Market: 07:21
Emergent BioSolutions Price to Book Value : 0.9361 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.9361 |
| September 10, 2026 | 0.882 |
| September 09, 2026 | 0.8535 |
| September 08, 2026 | 0.9016 |
| September 04, 2026 | 0.9331 |
| September 03, 2026 | 0.9361 |
| September 02, 2026 | 0.9707 |
| September 01, 2026 | 0.9346 |
| August 31, 2026 | 0.9166 |
| August 28, 2026 | 0.8881 |
| August 27, 2026 | 0.8926 |
| August 26, 2026 | 0.8971 |
| August 25, 2026 | 0.8475 |
| August 24, 2026 | 0.7784 |
| August 21, 2026 | 0.7633 |
| August 20, 2026 | 0.7243 |
| August 19, 2026 | 0.7348 |
| August 18, 2026 | 0.7002 |
| August 17, 2026 | 0.6762 |
| August 14, 2026 | 0.6897 |
| August 13, 2026 | 0.6747 |
| August 12, 2026 | 0.6837 |
| August 11, 2026 | 0.6687 |
| August 10, 2026 | 0.6717 |
| August 07, 2026 | 0.7273 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.7979 |
| August 05, 2026 | 1.133 |
| August 04, 2026 | 1.138 |
| August 03, 2026 | 1.114 |
| July 31, 2026 | 1.085 |
| July 30, 2026 | 1.091 |
| July 29, 2026 | 1.104 |
| July 28, 2026 | 1.098 |
| July 27, 2026 | 1.101 |
| July 24, 2026 | 1.091 |
| July 23, 2026 | 1.127 |
| July 22, 2026 | 1.139 |
| July 21, 2026 | 1.150 |
| July 20, 2026 | 1.156 |
| July 17, 2026 | 1.146 |
| July 16, 2026 | 1.156 |
| July 15, 2026 | 1.186 |
| July 14, 2026 | 1.127 |
| July 13, 2026 | 1.204 |
| July 10, 2026 | 1.210 |
| July 09, 2026 | 1.229 |
| July 08, 2026 | 1.223 |
| July 07, 2026 | 1.246 |
| July 06, 2026 | 1.229 |
| July 02, 2026 | 1.244 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Exelixis, Inc. | 7.576 |
| Capricor Therapeutics, Inc. | 1.975 |
| ADMA Biologics, Inc. | 5.096 |
| Akebia Therapeutics, Inc. | 10.34 |
| Arcutis Biotherapeutics, Inc. | 13.60 |
Price to Book Value Related Metrics
| PS Ratio | 0.4388 |
| Price to Free Cash Flow | 3.934 |
| Price | 6.23 |
| Earnings Yield | -57.04% |
| Market Cap | 319.60M |
| Operating PE Ratio | 2.469 |